Lipid‐Lowering Trials Are Not Representative of Patients Managed in Clinical Practice: A Systematic Review and Meta‐Analysis of Exclusion Criteria
Background Randomized clinical trials (RCTs) might not be representative of the real‐world population because of unreasonable exclusion criteria. We sought to determine which groups of patients are excluded from RCTs that included lipid‐lowering therapy. Methods and Results We retrieved all trials f...
Main Authors: | Martina Aeschbacher‐Germann, Nathalie Kaiser, Alexandre Speierer, Manuel R. Blum, Douglas C. Bauer, Cinzia Del Giovane, Drahomir Aujesky, Baris Gencer, Nicolas Rodondi, Elisavet Moutzouri |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.122.026551 |
Similar Items
-
Lipid‐Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
by: Sylvain Bétrisey, et al.
Published: (2024-02-01) -
Is there a shift from cardiovascular to cancer death in lipid-lowering trials? A systematic review and meta-analysis
by: Lucy Bolt, et al.
Published: (2024-01-01) -
Is there a shift from cardiovascular to cancer death in lipid-lowering trials? A systematic review and meta-analysis.
by: Lucy Bolt, et al.
Published: (2024-01-01) -
Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population
by: Luise Adam, et al.
Published: (2023-09-01) -
Exclusion criteria and generalizability in bipolar disorder treatment trials
by: Jessie J. Wong, et al.
Published: (2018-03-01)